AstraZeneca Pharma India achieves 31% revenue growth in Q1 FY25
The results are an outcome of the company's focus on sustainable and profitable growth and reflects all the hard work and focus teams have put in over the years
The results are an outcome of the company's focus on sustainable and profitable growth and reflects all the hard work and focus teams have put in over the years
Organization to provide vaccinations & treatments for several monsoon related diseases and illnesses across all 102 clinics
The pharma market is showing encouraging signs of improvement, positioning us well for future growth
Expect the international business including CDMO business to pick-up in the second half of the financial year
The drugmaker's net profit slipped 26 per cent on-year to Rs 143.8 crore
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
He advocated for a "PPP + PPP" collaboration, urging the public and private sectors within India to partner with their counterparts in other countries
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
Narayana Hrudayalaya has reported total income of Rs. 1364.44 crores during the period ended June 30, 2024
Vijaya Diagnostic Centre has reported total income of Rs. 159.78 crores during the quarter ended June 30, 2024
Subscribe To Our Newsletter & Stay Updated